Research Peptides in Texas

Nationwide shipping to Texas

Researchers throughout Texas can order the full catalog of 33 research peptides for delivery statewide. Because peptides ship as a stable lyophilized powder, Texas orders arrive ready for refrigerated storage and reconstitution. Every lot is third-party tested to a 99%+ purity target with a Certificate of Analysis available on request - the same standard whether you are in a major Texas metro or a smaller research community. Identity is confirmed by mass spectrometry and purity is quantified by HPLC, and each vial is tied to a tracked lot so Texas research records stay defensible.

Research peptide categories shipped across Texas

The catalog spans seven research areas. Texas researchers most often work across tissue-repair, metabolic, and growth-hormone categories, but the full range below ships statewide.

Most-studied research peptides in Texas

The following compounds are among the most-requested by Texas research programs. Each profile below is drawn from the published research literature and is provided for laboratory context only.

Gonadorelin (GnRH) research

Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH). It is studied for its role in stimulating the pituitary to release luteinizing hormone and follicle-stimulating hormone in a pulsatile pattern.

Research mechanism. Gonadorelin research focuses on pulsatile GnRH-receptor activation - the natural rhythm matters, so frequent administration is modeled to mimic endogenous pulses.

Reproductive-hormone research. Studied for LH/FSH stimulation endpoints.

Pulsatile-signaling research. Examined for the importance of pulse frequency in models.

Hormone-axis maintenance research. Studied in models of endogenous hormone production.

How it compares. Gonadorelin is GnRH itself; Kisspeptin acts upstream of it, and HCG mimics LH downstream - three distinct points in the hormone axis.

Research pairings. Generally studied as a standalone GnRH peptide.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily in pulsatile designs. Reference values only.

Full Gonadorelin research profile → · Specialty peptides

Ipamorelin (selective GHRP) research

Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). In research it is valued for being one of the most selective GHRPs, reported to stimulate GH release with minimal effect on cortisol or prolactin compared with older GHRPs.

Research mechanism. Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.

Selective GH-release research. Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.

GHRH synergy models. Most often studied with CJC-1295 to amplify GH pulses.

Body-composition and recovery research. Downstream metabolic and recovery endpoints are studied in models.

How it compares. Compared with GHRP-6 and GHRP-2, Ipamorelin is studied as the most selective option with the least off-target hormonal signaling; compared with Hexarelin it is gentler but less potent.

Research pairings. Ipamorelin + CJC-1295 (no DAC) is the standard research stack for amplified, relatively clean GH release.

Reference research values. Research references commonly cite 200-300 mcg before rest periods on a 5-7 day schedule. Reference values only.

Full Ipamorelin research profile → · Growth Hormone & Muscle peptides

Vesugen (KED Vascular Bioregulator) research

Vesugen is a short vascular peptide bioregulator (a tripeptide, KED) from the Khavinson family, studied for endothelial and vessel-wall support signaling in research models. It is the vascular-tissue member of the short-peptide bioregulator group.

Research mechanism. Vesugen research focuses on vascular and endothelial tissue bioregulation - the concept that a tissue-specific short peptide can support normal endothelial function and vessel-wall protein synthesis - within cardiovascular-tissue research models.

Vascular / endothelial research. Studied for endothelial-function and vessel-support endpoints in models.

Cardiovascular-tissue research. Examined in bioregulator research focused on vascular tissue normalization.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator framework.

How it compares. Vesugen is the vascular/endothelial bioregulator, distinct from the organ bioregulator Ovagen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Ovagen, Pinealon) in tissue-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Vesugen research profile → · Specialty peptides

GHK-Cu (Copper Peptide) research

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.

Research mechanism. Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.

Skin and tissue regeneration research. GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.

Hair-follicle research. It appears frequently in hair-growth and follicle-signaling research models.

Anti-inflammatory and antioxidant studies. Its copper-transport role is studied for redox and inflammation endpoints.

How it compares. GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.

Research pairings. In regenerative research GHK-Cu is sometimes paired with BPC-157 or TB-500 to model both structural and dermal repair.

Reference research values. Research references commonly cite 1-2 mg administered 3-5 times per week. Reference values only.

Full GHK-Cu research profile → · Healing & Recovery peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

VIP (Vasoactive Intestinal Peptide) research

VIP (vasoactive intestinal peptide) is a naturally occurring neuropeptide with broad signaling roles. It is studied in specialized research contexts including immune regulation and biotoxin-related research models.

Research mechanism. VIP research focuses on VPAC-receptor signaling, with interest in immune modulation, inflammation, and vascular endpoints.

Immune-regulation research. Studied for immune-signaling endpoints in models.

Inflammation research. Examined for anti-inflammatory signaling.

Biotoxin-illness research. Used in specialized research designs.

How it compares. VIP occupies a specialized research niche distinct from the structural, metabolic, and cognitive peptides.

Research pairings. Generally studied as a standalone specialized peptide.

Reference research values. Research references commonly cite 50 mcg four times daily (intranasal model) over extended study windows. Reference values only - a specialized compound.

Full VIP research profile → · Specialty peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

Semaglutide (GLP-1 agonist) research

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a long half-life. It is among the most-studied metabolic research peptides because of the extensive GLP-1 literature on glucose handling and satiety signaling.

Research mechanism. Semaglutide research centers on GLP-1-receptor activation: enhanced glucose-dependent insulin signaling, slowed gastric emptying, and central satiety pathways. These endpoints are studied in metabolic and weight-related research models.

Weight-management research. The dominant research theme is appetite and body-weight modeling via GLP-1 signaling.

Glucose-metabolism research. Studied for glucose-dependent insulin and metabolic endpoints.

Comparative GLP-1 studies. Frequently compared with Tirzepatide in dual-pathway research.

How it compares. Semaglutide is a single-pathway GLP-1 agonist; Tirzepatide is a dual GLP-1/GIP agonist. The two are the central comparison in modern metabolic-peptide research.

Research pairings. In research it is studied as a standalone GLP-1 model or compared head-to-head with Tirzepatide.

Reference research values. Research references describe a titration model from 0.25 mg up to 2.4 mg weekly over several weeks. Reference values only.

Full Semaglutide research profile → · Fat Loss & Weight Management peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

DSIP (Delta Sleep-Inducing Peptide) research

DSIP (delta sleep-inducing peptide) is a naturally occurring neuropeptide studied for its reported association with delta-wave sleep and stress regulation. The research literature is mixed, which makes it an active area of investigation.

Research mechanism. DSIP research examines its role in sleep architecture, stress-hormone modulation, and pain endpoints, though the exact mechanism remains a research question.

Sleep research. Studied for sleep-quality and delta-wave endpoints in models.

Stress-regulation research. Examined for stress-hormone modulation.

Pain-modulation research. Used in exploratory pain-endpoint designs.

How it compares. DSIP is studied specifically for sleep and stress endpoints, distinct from the hormone and cognitive peptides.

Research pairings. Generally studied as a standalone sleep-research peptide.

Reference research values. Research references commonly cite 100-300 mcg before rest periods, used as-needed. Reference values only.

Full DSIP research profile → · Specialty peptides

KPV (Lysine-Proline-Valine) research

KPV is the C-terminal tripeptide (lysine-proline-valine) of the alpha-melanocyte-stimulating hormone. In research it is studied because it retains anti-inflammatory activity associated with the parent hormone without the pigmentation effects, making it a clean model compound for inflammation studies.

Research mechanism. KPV research focuses on its reported ability to enter cells and modulate inflammatory transcription pathways (such as NF-kB signaling), reducing pro-inflammatory cytokine output in models of gut and tissue inflammation.

Gut inflammation models. KPV is studied in models relevant to inflammatory bowel research (such as colitis and Crohn-type models) where epithelial inflammation is the variable.

General anti-inflammatory research. It is used as a model peptide for systemic and tissue inflammation studies with minimal off-target signaling.

Immune-modulation research. Its melanocortin lineage makes it relevant to immune-signaling investigations.

How it compares. Unlike BPC-157 and TB-500, which are studied for structural tissue repair, KPV is studied specifically for inflammatory signaling, making it complementary rather than competitive.

Research pairings. In healing research KPV is sometimes studied alongside BPC-157 for combined repair-and-inflammation models.

Reference research values. Research references commonly cite 500-1,000 mcg daily across a 4-12 week study window. Reference values only - not dosing for any subject.

Full KPV research profile → · Healing & Recovery peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

Melanotan I (Afamelanotide) research

Melanotan I (afamelanotide) is a linear analog of alpha-MSH that is more selective than Melanotan II, studied for melanogenesis endpoints with fewer of the off-target effects reported for MT-II.

Research mechanism. Melanotan I research focuses on MC1R-mediated melanin synthesis, the pathway central to pigmentation research, with a more selective profile than the non-selective MT-II.

Pigmentation research. Studied for melanogenesis endpoints with a selective profile.

Photoprotection research. Examined in models of UV response.

Melanocortin-receptor research. A more selective MC1R model compound.

How it compares. Melanotan I is more selective and reportedly better tolerated in models than Melanotan II, with a narrower pigmentation focus.

Research pairings. Generally studied as a standalone selective melanocortin agonist.

Reference research values. Research references commonly cite a loading figure of 0.5-1 mg daily followed by 2-3 times weekly maintenance. Reference values only.

Full Melanotan I research profile → · Sexual Health & Tanning peptides

N-Acetyl Semax Amidate (potent Semax analog) research

N-Acetyl Semax Amidate is a modified version of Semax with acetylation and amidation that the literature associates with greater potency and a longer active window in cognitive-research models.

Research mechanism. Like Semax, it is studied for BDNF and nerve-growth-factor signaling and monoamine modulation, with the modifications extending stability and duration in models.

Advanced cognitive research. Studied for focus, learning, and mental-clarity endpoints with a longer duration.

Neuroprotection research. Examined in neural-stress and recovery models.

BDNF-signaling research. A more stable model compound for neurotrophic studies.

How it compares. It is studied as more potent and longer-lasting than standard Semax, suited to demanding cognitive-research models.

Research pairings. Studied alongside Selank in cognitive-research designs.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full N-Acetyl Semax Amidate research profile → · Cognitive & Neurological peptides

Research applications studied in Texas labs

• Reproductive-hormone research (Gonadorelin). Studied for LH/FSH stimulation endpoints.
• Selective GH-release research (Ipamorelin). Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.
• Vascular / endothelial research (Vesugen). Studied for endothelial-function and vessel-support endpoints in models.
• Skin and tissue regeneration research (GHK-Cu). GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.
• Growth-hormone release research (CJC-1295). The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Cities we ship to in Texas

Ordering & research-use in Texas

Orders to Texas are placed through the Peptides Factory Direct portal as one-time or recurring research purchases. Checkout requires confirming you are 21 or older and purchasing for laboratory research only. As with all jurisdictions, Texas researchers are responsible for compliance with applicable state and local laws; products are research-use-only and not for human or animal consumption. Open the order portal.

Frequently asked questions

All states · Research guides · Price comparison

External references: Texas (Wikipedia) · U.S. Census Bureau